Vicarious Surgical Inc. Announces 2024 Annual Meeting of Stockholders

TL;DR

Vicarious Surgical Inc. will hold its 2024 annual meeting on June 10, 2024, via webcast, with proposals including director elections, equity plan amendments, a reverse stock split, and auditor ratification.

AI Summary

Vicarious Surgical Inc. (RBOTW) filed a Proxy Statement (DEF 14A) with the SEC on April 23, 2024. The 2024 annual meeting of stockholders for Vicarious Surgical Inc. will be held on June 10, 2024, at 2:00 p.m. Eastern Time. The meeting will be conducted solely via live audio webcast on the Internet at www.virtualshareholdermeeting.com/RBOT2024. Key proposals include the election of seven directors, an amendment to the 2021 Equity Incentive Plan, and an amendment to the Certificate of Incorporation to effect a reverse stock split. Stockholders will also vote to ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024. The company is utilizing the 'notice and access' method to deliver proxy materials over the Internet to certain stockholders.

Why It Matters

For investors and stakeholders tracking Vicarious Surgical Inc., this filing contains several important signals. The reverse stock split proposal could impact the company's stock price and trading dynamics. The ratification of Deloitte & Touche LLP as auditor is a standard but crucial step for financial transparency and investor confidence.

Risk Assessment

Risk Level: — Vicarious Surgical Inc. shows moderate risk based on this filing. The filing is a routine proxy statement for an annual meeting, with no immediate financial or operational concerns highlighted.

Analyst Insight

Stockholders should review the proxy materials carefully to understand the implications of the proposed reverse stock split and equity plan amendments before voting.

Key Numbers

• 7 — Directors to be elected (Number of directors to be elected at the annual meeting.)
• 2:00 p.m. — Meeting Time (Time of the annual meeting.)
• 2024 — Fiscal Year End (Fiscal year for which Deloitte & Touche LLP is being ratified as auditor.)

Key Players & Entities

• Vicarious Surgical Inc. (company) — Registrant name
• Deloitte & Touche LLP (company) — Independent registered public accounting firm
• June 10, 2024 (date) — Date of annual meeting
• 2021 Equity Incentive Plan (plan) — Plan to be amended

FAQ

Risk Factors

• Compliance with SEC Regulations [low — regulatory]: The company must comply with SEC rules regarding proxy solicitations and disclosures for the annual meeting.
• Reverse Stock Split Impact [medium — financial]: The proposed reverse stock split could affect the market price and liquidity of the company's common stock.
• Virtual Meeting Logistics [low — operational]: Ensuring a smooth and accessible virtual meeting experience for all stockholders is critical for engagement.

Key Dates

• 2024-06-10: Annual Meeting of Stockholders — Key date for voting on proposals and electing directors.
• 2024-04-23: Filing Date — Date the proxy statement was filed with the SEC.

Glossary

DEF 14A

Definitive Proxy Statement filed with the SEC. (Indicates the type of filing and its purpose for shareholder communication.)

Reverse Stock Split

A corporate action to reduce the number of outstanding shares of common stock. (A key proposal that will be voted on by stockholders, potentially impacting share price.)

Proxy Statement

A document providing information to shareholders about matters to be voted on at a company meeting. (The primary document for this filing, containing all details for the annual meeting.)

Key Financial Figures

• $0.0001 — ng Class A common stock, par value $0.0001 per share (the “Class A com

Filing Documents

• ny20021316x2_def14a.htm (DEF 14A) — 943KB
• logo_vicarious.jpg (GRAPHIC) — 25KB
• ny20021316x2_pc1.jpg (GRAPHIC) — 700KB
• ny20021316x2_pc2.jpg (GRAPHIC) — 587KB
• sig_asachs.jpg (GRAPHIC) — 14KB
• 0001140361-24-021339.txt ( ) — 2770KB

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT ​ ​ 6 MANAGEMENT AND CORPORATE GOVERNANCE ​ ​ 8 EXECUTIVE OFFICER AND DIRECTOR COMPENSATION ​ ​ 14 EQUITY COMPENSATION PLAN INFORMATION ​ ​ 20 REPORT OF AUDIT COMMITTEE ​ ​ 21 DELINQUENT SECTION 16(a) REPORTS ​ ​ 22 CERTAIN RELATIONSHIPS AND RELATED PERSON TRANSACTIONS ​ ​ 23 PROPOSAL NO. 1 ELECTION OF DIRECTORS ​ ​ 25 PROPOSAL NO. 2 APPROVAL OF AN AMENDMENT TO THE VICARIOUS SURGICAL INC. 2021 EQUITY INCENTIVE PLAN ​ ​ 26 PROPOSAL NO. 3 THE REVERSE SPLIT PROPOSAL ​ ​ 33 PROPOSAL NO. 4 RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ​ ​ 40 CODE OF CONDUCT AND ETHICS ​ ​ 42 OTHER MATTERS ​ ​ 42 STOCKHOLDER PROPOSALS AND NOMINATIONS FOR DIRECTOR ​ ​ 42 Appendices Appendix A - Vicarious Surgical Inc. 2021 Equity Incentive Plan, as amended. Appendix B - Certificate of Amendment to Certificate of Incorporation, as amended, of Vicarious Surgical Inc. i TABLE OF CONTENTS PRELIMINARY COPIES FILED PURSUANT TO RULE 14a-6(a)   Vicarious Surgical Inc. 78 Fourth Avenue Waltham, Massachusetts 02451 PROXY STATEMENT FOR THE VICARIOUS SURGICAL INC. ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON JUNE 10, 2024 This proxy statement, along with the accompanying notice of 2024 annual meeting of stockholders, contains information about the 2024 annual meeting of stockholders of Vicarious Surgical Inc., including any adjournments or postponements of the annual meeting. We are holding the annual meeting at 2:00 p.m., Eastern Time, on Monday, June 10, 2024. We have decided to hold this year’s annual meeting virtually via live webcast on the Internet. We believe hosting a virtual annual meeting enables greater stockholder attenda

View Full Filing

View this DEF 14A filing on SEC EDGAR